Annual Shareholders Equity
$445.45 M
+$375.78 M+539.38%
December 31, 2024
Summary
- As of March 12, 2025, PRAX annual stockholders equity is $445.45 million, with the most recent change of +$375.78 million (+539.38%) on December 31, 2024.
- During the last 3 years, PRAX annual shareholders equity has risen by +$194.64 million (+77.60%).
- PRAX annual shareholders equity is now at all-time high.
Performance
PRAX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$445.45 M
+$62.78 M+16.41%
December 31, 2024
Summary
- As of March 12, 2025, PRAX quarterly stockholders equity is $445.45 million, with the most recent change of +$62.78 million (+16.41%) on December 31, 2024.
- Over the past year, PRAX quarterly shareholders equity has increased by +$62.78 million (+16.41%).
- PRAX quarterly shareholders equity is now at all-time high.
Performance
PRAX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PRAX Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +539.4% | +16.4% |
3 y3 years | +77.6% | +591.0% |
5 y5 years | +1010.5% | +591.0% |
PRAX Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +539.4% | at high | +591.0% |
5 y | 5-year | at high | +1010.5% | at high | +3057.9% |
alltime | all time | at high | +2934.0% | at high | +3057.9% |
Praxis Precision Medicines Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $445.45 M(+539.4%) | $445.45 M(+16.4%) |
Sep 2024 | - | $382.67 M(-8.7%) |
Jun 2024 | - | $419.10 M(+82.5%) |
Mar 2024 | - | $229.68 M(+229.7%) |
Dec 2023 | $69.67 M(-8.5%) | $69.67 M(-19.7%) |
Sep 2023 | - | $86.76 M(-17.9%) |
Jun 2023 | - | $105.63 M(+63.8%) |
Mar 2023 | - | $64.47 M(-15.3%) |
Dec 2022 | $76.11 M | $76.11 M(-27.6%) |
Sep 2022 | - | $105.16 M(-24.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $138.87 M(-27.3%) |
Mar 2022 | - | $191.02 M(-23.8%) |
Dec 2021 | $250.81 M(-12.7%) | $250.81 M(-15.2%) |
Sep 2021 | - | $295.92 M(-11.3%) |
Jun 2021 | - | $333.77 M(+25.7%) |
Mar 2021 | - | $265.51 M(-7.6%) |
Dec 2020 | $287.46 M(+616.6%) | $287.46 M(+163.8%) |
Sep 2020 | - | $108.97 M(+672.5%) |
Jun 2020 | - | $14.11 M(-64.8%) |
Dec 2019 | $40.11 M(+173.2%) | $40.11 M |
Dec 2018 | $14.68 M | - |
FAQ
- What is Praxis Precision Medicines annual stockholders equity?
- What is the all time high annual shareholders equity for Praxis Precision Medicines?
- What is Praxis Precision Medicines annual shareholders equity year-on-year change?
- What is Praxis Precision Medicines quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Praxis Precision Medicines?
- What is Praxis Precision Medicines quarterly shareholders equity year-on-year change?
What is Praxis Precision Medicines annual stockholders equity?
The current annual shareholders equity of PRAX is $445.45 M
What is the all time high annual shareholders equity for Praxis Precision Medicines?
Praxis Precision Medicines all-time high annual stockholders equity is $445.45 M
What is Praxis Precision Medicines annual shareholders equity year-on-year change?
Over the past year, PRAX annual stockholders equity has changed by +$375.78 M (+539.38%)
What is Praxis Precision Medicines quarterly stockholders equity?
The current quarterly shareholders equity of PRAX is $445.45 M
What is the all time high quarterly shareholders equity for Praxis Precision Medicines?
Praxis Precision Medicines all-time high quarterly stockholders equity is $445.45 M
What is Praxis Precision Medicines quarterly shareholders equity year-on-year change?
Over the past year, PRAX quarterly stockholders equity has changed by +$62.78 M (+16.41%)